133 related articles for article (PubMed ID: 26562037)
1. Added value of indirect immunofluorescence intensity of automated antinuclear antibody testing in a secondary hospital setting.
Oyaert M; Bossuyt X; Ravelingien I; Van Hoovels L
Clin Chem Lab Med; 2016 Feb; 54(2):e63-6. PubMed ID: 26562037
[No Abstract] [Full Text] [Related]
2. Value-added reporting of antinuclear antibody testing by automated indirect immunofluorescence analysis.
Schouwers S; Bonnet M; Verschueren P; Westhovens R; Blockmans D; Mariën G; Bossuyt X
Clin Chem Lab Med; 2014 Apr; 52(4):547-51. PubMed ID: 24225130
[TBL] [Abstract][Full Text] [Related]
3. Predictive autoimmunity using autoantibodies: screening for anti-nuclear antibodies.
Pérez D; Gilburd B; Cabrera-Marante Ó; Martínez-Flores JA; Serrano M; Naranjo L; Pleguezuelo D; Morillas L; Shovman O; Paz-Artal E; Shoenfeld Y; Serrano A
Clin Chem Lab Med; 2018 Sep; 56(10):1771-1777. PubMed ID: 28628475
[No Abstract] [Full Text] [Related]
4. Dense fine speckled indirect immunofluorescence pattern in an Australian population.
Broadfoot A; Sivertsen T; Baumgart K
Pathology; 2016 Apr; 48(3):247-50. PubMed ID: 27020500
[TBL] [Abstract][Full Text] [Related]
5. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay.
Op De Beeck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
Autoimmun Rev; 2011 Oct; 10(12):801-8. PubMed ID: 21741497
[TBL] [Abstract][Full Text] [Related]
6. Analytical performance of the single well titer function of NOVA View®: good enough to omit ANA IIF titer analysis?
Van Hoovels L; Schouwers S; Van den Bremt S; Bogaert L; Vandeputte N; Vercammen M; Bossuyt X
Clin Chem Lab Med; 2018 Oct; 56(11):258-261. PubMed ID: 29804100
[No Abstract] [Full Text] [Related]
7. [Importance of the dense fine speckled pattern and anti-DFS70 antibodies for the diagnosis of systemic autoimmune rheumatic diseases].
López Sañudo S; Fernández Alonso I; López Hoyos M
Med Clin (Barc); 2015 Sep; 145(5):218-23. PubMed ID: 26021571
[No Abstract] [Full Text] [Related]
8. How to use... antinuclear antibodies in paediatric rheumatic diseases.
Weaver LK; Behrens EM
Arch Dis Child Educ Pract Ed; 2013 Apr; 98(2):64-70. PubMed ID: 23492397
[No Abstract] [Full Text] [Related]
9. Impact of the routine implementation of automated indirect immunofluorescence antinuclear antibody analysis: 1 year of experience.
Mulliez SM; Maenhout TM; Bonroy C
Clin Chem Lab Med; 2016 Jul; 54(7):e183-6. PubMed ID: 26562038
[No Abstract] [Full Text] [Related]
10. [Determination of autoimmune antibodies using Western blot technique in the routine laboratory. Problems with determining and comparing three test kits].
Bauerfeind S; Heide KG
Z Rheumatol; 1994; 53(2):66-71. PubMed ID: 8023587
[TBL] [Abstract][Full Text] [Related]
11. Anti-nuclear antibodies in daily clinical practice: prevalence in primary, secondary, and tertiary care.
Avery TY; van de Cruys M; Austen J; Stals F; Damoiseaux JG
J Immunol Res; 2014; 2014():401739. PubMed ID: 24741596
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic profile on the IFA 40: HEp-20-10 - an immunofluorescence test for reliable antinuclear antibody screening.
Rohwäder E; Locke M; Fraune J; Fechner K
Expert Rev Mol Diagn; 2015 Apr; 15(4):451-62. PubMed ID: 25530004
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic laboratory tests for systemic autoimmune rheumatic diseases: unmet needs towards harmonization.
Meroni PL; Borghi MO
Clin Chem Lab Med; 2018 Sep; 56(10):1743-1748. PubMed ID: 29708880
[No Abstract] [Full Text] [Related]
14. The association of solid-phase assays to immunofluorescence increases the diagnostic accuracy for ANA screening in patients with autoimmune rheumatic diseases.
Bizzaro N; Brusca I; Previtali G; Alessio MG; Daves M; Platzgummer S; Cinquanta L; Paura G; Infantino M; Manfredi M; Faricelli R; Bassetti D; Musso M; Deleonardi G; Trevisan MT; Radice A; Liguori M; Imbastaro T; Pesente F; Fabris M; Tonutti E
Autoimmun Rev; 2018 Jun; 17(6):541-547. PubMed ID: 29631063
[No Abstract] [Full Text] [Related]
15. Harmonization of clinical interpretation of antinuclear antibody test results by solid phase assay and by indirect immunofluorescence through likelihood ratios.
Bossuyt X; Claessens J; Belmondo T; De Langhe E; Westhovens R; Poesen K; Hüe S; Blockmans D; Fritzler MJ; Mahler M; Fierz W
Autoimmun Rev; 2019 Nov; 18(11):102386. PubMed ID: 31520795
[No Abstract] [Full Text] [Related]
16. Detection of antinuclear antibodies by automated indirect immunofluorescence analysis.
Bossuyt X; Cooreman S; De Baere H; Verschueren P; Westhovens R; Blockmans D; Mariën G
Clin Chim Acta; 2013 Jan; 415():101-6. PubMed ID: 23026234
[TBL] [Abstract][Full Text] [Related]
17. Automated Processing and Evaluation of Anti-Nuclear Antibody Indirect Immunofluorescence Testing.
Ricchiuti V; Adams J; Hardy DJ; Katayev A; Fleming JK
Front Immunol; 2018; 9():927. PubMed ID: 29780386
[TBL] [Abstract][Full Text] [Related]
18. Antinuclear antibody profiling in uveitis.
Ten Berge JC; Groen-Hakan F; Rothova A; Schreurs MWJ
Acta Ophthalmol; 2018 Aug; 96(5):e660-e661. PubMed ID: 29461672
[No Abstract] [Full Text] [Related]
19. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
Sebastian W; Roy A; Kini U; Mullick S
Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
[TBL] [Abstract][Full Text] [Related]
20. Detection and identification of antinuclear antibodies (ANA) in a large community hospital.
Verstegen G; Duyck MC; Meeus P; Ravelingien I; De Vlam K
Acta Clin Belg; 2009; 64(4):317-23. PubMed ID: 19810418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
